Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2

被引:400
|
作者
Gorina, S
Pavletich, NP
机构
[1] Cell. Biochem. and Biophys. Program, Mem. Sloan-Kettering Cancer Center, New York
关键词
D O I
10.1126/science.274.5289.1001
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mutations in the p53 tumor suppressor are among the most frequently observed genetic alterations in human cancer and map to the 200-amino acid core domain of the protein. The core domain contains the sequence-specific DNA binding activity and the in vitro 53BP2 protein binding activity of p53. The crystal structure of the p53 core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure-consisting of a 3 hairpin and two ct helices, binds the L2 loop of p53. The structure of the complex shows that the 53BP2 binding site on the p53 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding. The six most frequently observed p53 mutations disrupt 53BP2 binding in vitro. The structure provides evidence that the 53BP2-p53 complex forms in vivo and may have a critical role in the p53 pathway of tumor suppression.
引用
收藏
页码:1001 / 1005
页数:5
相关论文
共 50 条
  • [1] Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor
    Derbyshire, DJ
    Basu, BP
    Serpell, LC
    Joo, WS
    Date, T
    Iwabuchi, K
    Doherty, AJ
    EMBO JOURNAL, 2002, 21 (14): : 3863 - 3872
  • [2] Erratum To: Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor
    Dean J. Derbyshire
    Balaku P. Basu
    Louise C. Serpell
    Woo S. Joo
    Takayasu Date
    Kuniyoshi Iwabuchi
    Aidan J. Doherty
    The EMBO Journal, 2002, 21 (21) : 5953 - 5953
  • [3] Characterisation of the in vivo properties of the p53 binding protein 53BP2
    Kernohan, NM
    Helps, NR
    Lane, DP
    Cohen, PTW
    JOURNAL OF PATHOLOGY, 1997, 181 : A34 - A34
  • [4] 53BP1-mediated activation of the tumor suppressor p53
    Belal, Hazrat
    Ng, Esther Feng Ying
    Meitinger, Franz
    CURRENT OPINION IN CELL BIOLOGY, 2024, 91
  • [5] Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53
    Lopez, CD
    Ao, Y
    Rohde, LH
    Perez, TD
    O'Connor, DJ
    Lu, X
    Ford, JM
    Naumovski, L
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (21) : 8018 - 8025
  • [6] p53的两种结合蛋白:53BP1和53BP2
    李虹
    姚开泰
    国外医学(分子生物学分册), 2000, (06) : 347 - 351
  • [7] Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
    Kussie, PH
    Gorina, S
    Marechal, V
    Elenbaas, B
    Moreau, J
    Levine, AJ
    Pavletich, NP
    SCIENCE, 1996, 274 (5289) : 948 - 953
  • [8] Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor (vol 21, pg 3863, 2002)
    Derbyshire, DJ
    Basu, BP
    Serpell, LC
    Joo, WS
    Date, T
    Iwabuchi, K
    Doherty, AJ
    EMBO JOURNAL, 2002, 21 (21): : 5953 - 5953
  • [9] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [10] Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2)
    Tidow, Henning
    Veprintsev, Dmitry B.
    Freund, Stefan M. V.
    Fersht, Alan R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (43) : 32526 - 32533